Skip to Main Content

Try STAT+ TODAY

The Aduhelm Files

All Coverage

The Aduhelm Files Rachel Cohrs, Adam Feuerstein and Damian Garde

FDA, Biogen, and an Alzheimer’s drug approval: 8 key takeaways from congressional investigation

The Aduhelm Files Damian Garde and Rachel Cohrs

In wake of House investigation, 5 burning questions for FDA, Biogen, and Alzheimer’s treatments

The Aduhelm Files Rachel Cohrs

‘Rife with irregularities’: Congressional investigation reveals FDA’s approval of Aduhelm marked by secret discussions, breaches of protocol

The Aduhelm Files Damian Garde and Adam Feuerstein

Seeking maximum profits, Biogen set an ‘unjustifiably high price’ for Alzheimer’s treatment, investigation finds